Clinical Trial Update: CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial update evaluating two-dose priming strategies for CIRN Pneumococcal Conjugate Vaccine, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pneumococcal Disease
• Streptococcus Pneumoniae Infection

Drugs mentioned

• CIRN Pneumococcal Conjugate Vaccine

Snippet

Sponsor: University of British Columbia | Conditions: Invasive Pneumococcal Disease, Protection Against, Streptococcus Pneumoniae Infection | Phase 2, Phase 3 | Status: COMPLETED